Literature DB >> 6745566

Different local therapeutic effects of various polysaccharides on MH134 hepatoma in mice and its relation to inflammation induced by the polysaccharides.

S Abe, K Takahashi, J Tsubouchi, K Aida, M Yamazaki, D Mizuno.   

Abstract

The local antitumor activities and inflammation-inducing activities of various antitumor polysaccharides were examined and the relation between the two types of activity was studied. The tested antitumor polysaccharides included MG (a mannoglucan prepared from the culture fluid of Microellobosporia grisea), lentinan, bacterial lipopolysaccharide, TAK (a glucan from Alcaligenes faecalis) and their derivatives. Local antitumor activity was tested by intratumoral administration of the polysaccharides 4, 7 and 10 days after inoculation of MH134 hepatoma intradermally (id) into the abdomen of C3H/He mice. MG and its derivatives showed strong local antitumor activity. Inflammation-inducing activity was assayed by measuring foot-pad swelling and accumulation of iv-injected 51Cr-labeled spleen cells after injection of the test materials into the footpads of C3H/He mice. TAK had the strongest inflammation-inducing activity among the polysaccharides tested. No close correlation was found between the local antitumor activity and the inflammation-inducing activity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6745566

Source DB:  PubMed          Journal:  Gan        ISSN: 0016-450X


  3 in total

1.  Update on the immunomodulating activities of glucans.

Authors:  N R Di Luzio
Journal:  Springer Semin Immunopathol       Date:  1985

2.  Local induction of a cytotoxic factor in a murine tumour by systemic administration of an antitumour polysaccharide, MGA.

Authors:  K Takahashi; Y Watanuki; M Yamazaki; S Abe
Journal:  Br J Cancer       Date:  1988-02       Impact factor: 7.640

3.  Suppression of neutrophil accumulation in mice by cutaneous application of geranium essential oil.

Authors:  Naho Maruyama; Yuka Sekimoto; Hiroko Ishibashi; Shigeharu Inouye; Haruyuki Oshima; Hideyo Yamaguchi; Shigeru Abe
Journal:  J Inflamm (Lond)       Date:  2005-02-10       Impact factor: 4.981

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.